Rua Bioscience Limited (NZE:RUA)
New Zealand · Delayed Price · Currency is NZD 0.0290
0.00 (0.00%)
Jan 9, 2026, 4:33 PM NZST
Rua Bioscience Market Cap
Rua Bioscience has a market cap or net worth of 9.8 million as of January 9, 2026. Its market cap has increased by 36.75% in one year.
Market Cap
9.80M
Enterprise Value
10.37M
Revenue
1.83M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.03
Market Cap Chart
Since October 22, 2020, Rua Bioscience's market cap has decreased from 95.21M to 9.80M, a decrease of -89.70%. That is a compound annual growth rate of -35.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 9.80M | 3.57% |
| Dec 31, 2025 | 9.47M | 54.80% |
| Dec 31, 2024 | 6.11M | -67.78% |
| Dec 29, 2023 | 18.98M | -44.14% |
| Dec 30, 2022 | 33.97M | -45.52% |
| Dec 31, 2021 | 62.37M | -25.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 22, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fisher & Paykel Healthcare Corporation | 22.80B |
| EBOS Group | 5.64B |
| Summerset Group Holdings | 3.01B |
| Ryman Healthcare | 2.99B |
| Oceania Healthcare | 659.05M |
| AFT Pharmaceuticals | 362.84M |
| Pacific Edge | 179.93M |
| Green Cross Health | 148.03M |